Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.51
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
1.82
Today|||52-Week Range
7.69
-31.98%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.51
Today’s open2.60
Day’s range2.50 - 2.60
Volume23,407
Average volume (3 months)239,582
Market cap$91.1M
Data as of 4:00pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)+40.08%
Earnings growth (this year)+36.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-73.62%
P/E ratioNM
Price/Sales135.22
Price/Book157.18

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp+0.00+0.08%
JNPJuniper Pharmaceutic...0.000.00%
MBRXMoleculin Biotech In...+0.08+4.97%
CHMAChiasma Inc-0.05-3.23%
Data as of 4:00pm ET, 05/24/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$669.0K
Annual profit (last year)-$35.5M
Net profit margin-5,300.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Dayton Misfeldt
CFO &
VP-Finance & Corporate Development
Willie Quinn
Corporate headquarters
South San Francisco, California

Forecasts